Mixture-of-Recursions (MoR) is a new AI architecture that promises to cut LLM inference costs and memory use without sacrificing performance.

According to the study, supply chain data governance is not just a technological necessity but a foundational enabler of ...

AI-native pharma disruptors like Palantir, Tempus, and Recursion are reshaping medicine. But ETFs still favor old-school ...

As AI gets more curious, security gaps widen. Explore the risks of prompt exfiltration and autonomous model behavior.

Harmonic raises $100M at nearly $900M valuation to scale AI model for formal mathematical reasoning - SiliconANGLE ...

Early intervention in psoriatic arthritis (PsA) is disease-modifying, and delays in diagnosis, even by 6 months, can reduce ...

For India, the stakes are especially high. Startups such as Gan.ai, Gnani.ai and Soket AI Labs, selected to build foundation models under the IndiaAI Mission, face a unique challenge: how to curate cl ...

Is ordering your study notes as overwhelming as cracking a cryptic crossword? Google’s new AI Mode update hopes to bring that disorganisation into shape, combining real-time visual help and ...

In an industry where 90 percent of drug candidates fail before reaching the market, a handful of startups are betting ...

The modern enterprise analytics landscape resembles a bustling financial district at rush hour—valuable data moving at lightning speed between towering infrastr ...

Yet that, more or less, is what is happening with the tech world’s pursuit of artificial general intelligence ( AGI ), ...

Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.